Why Are Altisource, MiMedx Group Inc, Qlik Technologies, and OvaScience Inc Plunging Today?

Qlik Technologies Inc (NASDAQ:QLIK)

• Elite Investors with Long Positions (as of June 30): 32
• Aggregate Value of Elite Investors’ Holdings (as of June 30): $865 Million
• Percentage of Shares Owned by Elite Investors (as of June 30): 27.10%

Qlik Technologies Inc (NASDAQ:QLIK) is the aforementioned tech stock, the company being a provider of the analytical software QlikView in addition to other business tools and services. Shares are down by 5.35% today, though it’s still enjoying a strong year overall, up by 18.45%. In a press release this morning, Qlik announced its new Qlik Proactive Support service for the detection of anomalies in networks and databases in real-time, which it believes will transform it from a reactive service into a more proactive (hence the name) one. However, investors are also worried about Amazon.com, Inc. (NASDAQ:AMZN)’s push into big data with Amazon Space Needle, and the effect it will have on companies like Qlik and Tableau Software Inc (NYSE:DATA). Qlik Technologies Inc (NASDAQ:QLIK) ranked as a top tech pick of ‘Tiger Cub’ Ian Murray as of June 30, with the investor’s fund Lanexa Global Management holding 100,000 shares.

OvaScience Inc. (NASDAQ:OVAS)

• Elite Investors with Long Positions (as of June 30): 14
• Aggregate Value of Elite Investors’ Holdings (as of June 30): $210 Million
• Percentage of Shares Owned by Elite Investors (as of June 30): 26.70%

Lastly is OvaScience Inc. (NASDAQ:OVAS), which has shed 7.22% of its market value today. Insiders seem to believe the company has reached rock bottom after a 74.31% drop this year, as two Directors of the fertility company recently purchased shares. OvaScience was forced to cut its guidance for 2015 at the end of September as overseas sales of its in-vitro fertilization product Augment, failed to meet expectations. Shares fell by over 40% on September 29 following the guidance cut, but have slowly trended back up since, gaining 34% even factoring in today’s pullback. Phill Gross and Robert Atchinson’s Adage Capital Management have been firm believers of OvaScience Inc. (NASDAQ:OVAS) since early 2014 and held 2.53 million shares on June 30.

Disclosure: None